SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 61.70 |
| Enterprise Value ($M) | 34.57 |
| Book Value ($M) | 25.37 |
| Book Value / Share | 0.40 |
| Price / Book | 2.43 |
| NCAV ($M) | 17.81 |
| NCAV / Share | 0.28 |
| Price / NCAV | 3.46 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.28 |
| Return on Assets (ROA) | -0.73 |
| Return on Equity (ROE) | -1.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.22 |
| Current Ratio | 2.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.26 |
| Assets | 44.81 |
| Liabilities | 19.44 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Slate Path Capital LP | 1.40 | -61.75 | |
| 13G/A | Bleichroeder LP | 9.99 | 122.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 67,124 | 193,008 | 34.78 | |
| 32,793 | 91,059 | 36.01 | |
| 54,942 | 168,758 | 32.56 | |
| 28,059 | 107,237 | 26.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CSBR – Champions Oncology, Inc. | CSCI – COSCIENS Biopharma Inc. |
| CTXR – Citius Pharmaceuticals, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
| CYCC – Cyclacel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io